What is it about?
Ethical considerations and concerns in allocating at random, treatment or indeed placebo, to patients afflicted with cancer. Will progress in cancer treatment suffer if randomised trials were abandoned, in favour of treating with new drugs, without randomisation, patients whose cancer has progressed against earlier treatments?
Featured Image
Why is it important?
Patients receiving treatment expect and are entitled to an anticipated benefit. Such perceived benefit, is not always served with randomised trials.
Read the Original
This page is a summary of: Treatment at Random: The Ultimate Science or the Betrayal of Hippocrates?, Journal of Clinical Oncology, December 2004, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2004.01.044.
You can read the full text:
Contributors
The following have contributed to this page